ARTICLE | Clinical News
BioSpring, Quark preclinical data
August 3, 2009 7:00 AM UTC
In a rat model of glaucoma, QPI-1007 administered 2 weeks after disease induction prevented retinal ganglion cell (RGC) loss, whereas RGC loss progressed in untreated controls. The siRNA against an un...